Yuanyuan Shan Selected Research

Ovomucin

6/2021	Ovomucin Ameliorates Intestinal Barrier and Intestinal Bacteria to Attenuate DSS-Induced Colitis in Mice.
11/2018	Sialic acid involves in the interaction between ovomucin and hemagglutinin and influences the antiviral activity of ovomucin.
9/2014	Mg2+ binding affects the structure and activity of ovomucin.
3/2012	Role of magnesium chloride on the purity and activity of ovomucin during the isolation process.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanyuan Shan Research Topics

Disease

4	Neoplasms (Cancer) 12/2017 - 01/2011
3	Colitis 10/2022 - 06/2021
3	Carcinogenesis 10/2022 - 12/2017
3	Infections 11/2018 - 01/2012
3	Virus Diseases (Viral Diseases) 09/2014 - 10/2011
2	Inflammation (Inflammations) 10/2022 - 02/2022
1	Colitis-Associated Neoplasms 02/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2021
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Metabolic Diseases (Metabolic Disease) 11/2020
1	Obesity 09/2020
1	Insulin Resistance 09/2020
1	Body Weight (Weight, Body) 09/2020
1	Influenza in Birds (Avian Flu) 11/2018
1	Pain (Aches) 01/2018
1	Acute Pain 01/2018
1	Pseudomonas Infections 01/2018
1	Cross Infection (Nosocomial Infection) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018

Drug/Important Bio-Agent (IBA)

4	OvomucinIBA 06/2021 - 03/2012
3	Dextran SulfateIBA 10/2022 - 12/2021
3	CytokinesIBA 10/2022 - 09/2020
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 03/2012
2	AzoxymethaneIBA 10/2022 - 02/2022
2	ChemokinesIBA 10/2022 - 02/2022
2	Glycoproteins (Glycoprotein)IBA 10/2021 - 10/2011
2	Phosphotransferases (Kinase)IBA 12/2017 - 02/2016
2	tyrosine receptor (receptor, tyrosine)IBA 12/2017 - 02/2016
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2017 - 12/2017
2	Neuraminidase (Sialidase)IBA 01/2012 - 10/2011
1	Anti-Infective Agents (Microbicides)IBA 12/2020
1	Bacteriocins (Lantibiotics)IBA 12/2020
1	Peptides (Polypeptides)IBA 11/2020
1	Hormones (Hormone)IBA 09/2020
1	Glucose (Dextrose)FDA LinkGeneric 09/2020
1	FructoseIBA 09/2020
1	LipidsIBA 09/2020
1	Messenger RNA (mRNA)IBA 09/2020
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2018
1	Hemagglutinins (Hemagglutinin)IBA 11/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	ApigeninIBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Dehydroepiandrosterone (DHEA)IBA 01/2018
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2018
1	CorticosteroneIBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2013
1	Histone Deacetylase InhibitorsIBA 12/2013
1	SaltsIBA 03/2012
1	Muramidase (Lysozyme)IBA 03/2012
1	Fluorouracil (Carac)FDA LinkGeneric 01/2011
1	AntimetabolitesIBA 01/2011

Therapy/Procedure

1	Therapeutics 12/2020